查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463134

食慾抑制劑市場、佔有率、規模、趨勢、行業分析報告：依藥物類別、依給藥途徑、依最終用戶、依地區、依細分市場、預測，2024-2032年

Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球食慾抑制劑市場規模預計將達到14.0313億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

全球食慾抑制劑市場的成長很大程度上是由於消費者對體重管理的興趣日益濃厚，這在某種程度上限制了食慾。 一類抑制食慾藥物的出現引發了消費者的興趣，並提高了作為控制熱量攝取手段的需求。 這是藥廠提高產能的動力。 例如，2024年2月，Novo Holdings宣佈策略以165億美元收購Catalent，以加速減重註射液Wegovy和糖尿病注射劑Ozempic的供應。

由於未來患有肥胖症的人數將大幅增加，研究期間市場對食慾管理藥物的需求將會很大。 根據世界肥胖聯合會2023年報告，預計到2035年，約有400萬人（佔世界人口的50%以上）患有肥胖症。

能量消耗與體力活動消耗的能量之間的差距不斷擴大是導致肥胖率上升的一個因素。 社群媒體使用的增加促使更多的人選擇改變以身體為中心的生活方式，這刺激了對食慾抑制劑等藥物的需求。 2023 年的一項研究發現，TikTok 和 Instagram 對美國有色人種年輕人的體重管理教育有很大影響力。

肥胖族群中心臟驟停、第二型糖尿病和某些癌症等慢性疾病的盛行率引起了向醫生諮詢治療的消費者的關注，以及在醫療機構中使用食慾抑制劑等肥胖抑制劑的關注。 科羅拉多大學博爾德分校 2023 年的一項研究發現，肥胖會使死亡風險增加，低至 22%，高至 91%。 另一項研究發現，當肥胖成年人透過飲食和體力活動減輕體重 5% 至 10% 時，他們罹患心血管疾病的風險就會降低。

越來越多的研究集中在治療肥胖和體重管理的新藥物配方創新上，預計這表明世界上對食慾抑制劑的需求量很大。 例如，2023年11月，美國食品藥物管理局（FDA）宣佈核准慢性體重管理注射藥物Zepbound（替澤帕肽）。 2024 年 1 月，禮來公司宣佈計劃明年將其肥胖藥物 Mounjaro 引進印度。

食慾抑制劑市場報告重點

由於兒茶酚胺產業在促進能源消耗方面的有效表現，預計未來幾年將出現最高成長。

由於給藥的便利性，口服藥物領域佔了最大的市場佔有率。

由於醫院為肥胖患者提供治療，因此預計醫院部門將獲得更大的收入佔有率。

由於肥胖盛行率不斷上升，預計亞太地區將在預測期內實現最快的成長。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球食慾抑制劑市場洞察

  • 食慾抑制劑市場 - 最終用戶快照
  • 食慾抑制劑市場動態
    • 推動者和機會
      • 體力活動少
      • 對減肥藥物的需求不斷增加
    • 抑制因素和課題
      • 監管障礙和副作用
  • PESTEL 分析
  • 食慾抑制劑市場終端用戶趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章依藥物類別劃分的世界市場

  • 主要發現
  • 簡介
  • 兒茶酚胺
  • 血清素

第 6 章依管理途徑劃分的全球市場

  • 主要發現
  • 簡介
  • 口頭
  • 皮下

第 7 章最終用戶的全球市場

  • 主要發現
  • 簡介
  • 業務銷售
  • 醫院
  • 診所
  • 零售銷售
  • 網路藥局
  • 郵購藥房

第 8 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年依地區劃分的食慾抑制劑市場評估
  • 食慾抑制劑市場 - 北美
    • 北美：食慾抑制劑市場，依藥物類別，2019-2032 年
    • 北美：食慾抑制劑市場，以最終用戶劃分，2019-2032 年
    • 北美：2019-2032 年食慾抑制劑市場（依給藥途徑）
    • 食慾抑制劑市場－美國
    • 食慾抑制劑市場 - 加拿大
  • 食慾抑制劑市場 - 歐洲
    • 歐洲：食慾抑制劑市場，依藥物類別，2019-2032 年
    • 歐洲：食慾抑制劑市場，以最終使用者劃分，2019-2032 年
    • 歐洲：2019-2032 年食慾抑制劑市場（依給藥途徑）
    • 食慾抑制劑市場 - 英國
    • 食慾抑制劑市場 - 法國
    • 食慾抑制劑市場 - 德國
    • 食慾抑制劑市場－義大利
    • 食慾抑制劑市場 - 西班牙
    • 食慾抑制劑市場 - 荷蘭
    • 食慾抑制劑市場 - 俄羅斯
  • 食慾抑制劑市場 - 亞太地區
    • 亞太地區：食慾抑制劑市場，依藥物類別，2019-2032 年
    • 亞太地區：2019-2032 年最終使用者的食慾抑制劑市場
    • 亞太地區：食慾抑制劑市場，依給藥途徑劃分，2019-2032 年
    • 食慾抑制劑市場 - 中國
    • 食慾抑制劑市場 - 印度
    • 食慾抑制劑市場 - 馬來西亞
    • 食慾抑制劑市場－日本
    • 食慾抑制劑市場－印度尼西亞
    • 食慾抑制劑市場－韓國
  • 食慾抑制劑市場 - 中東和非洲
    • 中東和非洲：2019-2032 年食慾抑制劑市場（依藥物類別）
    • 中東和非洲：2019-2032 年最終用戶的食慾抑制劑市場
    • 中東和非洲：2019-2032 年食慾抑制劑市場（依給藥途徑）
    • 食慾抑制劑市場 - 沙烏地阿拉伯
    • 食慾抑制劑市場 - 阿聯酋
    • 食慾抑制劑市場 - 以色列
    • 食慾抑制劑市場 - 南非
  • 食慾抑制劑市場 - 拉丁美洲
    • 拉丁美洲：食慾抑制劑市場，依藥物類別，2019-2032 年
    • 拉丁美洲：食慾抑制劑市場，依最終用戶劃分，2019-2032 年
    • 拉丁美洲：食慾抑制劑市場，依給藥途徑劃分，2019-2032 年
    • 食慾抑制劑市場 - 墨西哥
    • 食慾抑制劑市場 - 巴西
    • 食慾抑制劑市場－阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第十章公司簡介

  • AstraZeneca（UK）
  • Aurobindo Pharma（India）
  • Bausch Health Companies Inc.（Canada）
  • Cipla Inc.（US）
  • Currax Pharmaceuticals LLC（US）
  • Eisai Co., Ltd.（Japan）
  • F. Hoffmann-La Roche Ltd.（Switzerland）
  • GlaxoSmithKline plc（UK）
  • Johnson & Johnson Private Limited（US）
  • Lannett（US）
  • Merck & Co., Inc.（US）
  • Mylan N.V.（US）
  • Novartis AG（Switzerland）
Product Code: PM4793

The global anorexiants market size is expected to reach USD 1,403.13 million by 2032, according to a new study by Polaris Market Research. The report "Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the global anorexiants market is highly attributable to the rising consumer interest in weight management, which, in a way, limits appetite. The availability of the class of drugs that suppress appetite is gaining consumers attention as a measure to control calorie intake, creating higher demand. This is driving the pharmaceutical companies to enhance their production capacity. For instance, in February 2024, Novo Holdings unveiled its strategy to acquire Catalent to promote the supply of Wegovy, a weight loss injection, and Ozempic, a diabetic shot, for $16.5 billion.

As the number of people suffering from obesity grows significantly in the future, there will be a huge demand for appetite management drugs in the marketplace during the study period. According to the World Obesity Federation Report 2023, about 4 million people, which is more than 50% of the global population, are estimated to be obese by 2035.

The growing gap between energy consumption and energy spent on physical activities is the building factor leading to the rise in obesity. The increase in the number of people opting for lifestyle modification, with a higher focus on body look due to the growing use of social media, is stimulating the demand for appetite-control medications, such as anorexiants. A 2023 study found that TikTok and Instagram have a significant influence in educating weight management among youth of color in the United States.

The prevalence of chronic diseases, such as cardiac arrest, type 2 diabetes, and certain cancers, among obese people is grabbing the attention of consumers to consult doctors for treatment, facilitating the need for obese medications, including anorexiants, in healthcare settings. According to the University of Colorado Boulder Research in 2023, obesity increases the risk of death from a minimum of 22% to a maximum of 91%. According to another study, losing weight by 5-10% with diet and physical activities among obese people lowered the risk of developing cardiovascular disease among obese adults.

The growing research studies focusing on the innovation of new medication formulations for the treatment of obesity and weight management are anticipated to showcase significant demand for anorexiants in the world. For instance, in November 2023, the U.S. Food and Drug Administration (FDA) announced the approval of a chronic weight management injection, Zepbound (tirzepatide). In January 2024, Eli Lilly announced its plan to introduce the obesity drug Mounjaro in India in the next year.

Anorexiants Market Report Highlights

The catecholamines segment is anticipated to witness the highest growth in the coming years due to its effective performance in boosting energy expenditure.

Oral segment accounted for the largest market share owing to its convenience in taking medication.

The hospitals segment is projected to experience a larger revenue share due to the presence of hospitals offering treatment for obese patients.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the increasing incidence of obesity.

The global players include AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Cipla Inc., Currax Pharmaceuticals LLC, & Eisai Co., Ltd.

Polaris Market Research has segmented the anorexiants market report based on drug class, route of administration, end user and region:

Anorexiants, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Catecholamines
  • Serotonin

Anorexiants, Route of Admission Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Subcutaneous

Anorexiants, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Institutional sales
  • Hospitals
  • Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies

Anorexiants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anorexiants Market Insights

  • 4.1. Anorexiants Market - End User Snapshot
  • 4.2. Anorexiants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The presence of lower physical activity in the population
      • 4.2.1.2. Increase in the demand for weight-loss drugs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory hurdles and side effects
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anorexiants Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anorexiants Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • 5.3. Catecholamines
    • 5.3.1. Global Anorexiants Market, by Catecholamines, by Region, 2019-2032 (USD Million)
  • 5.4. Serotonin
    • 5.4.1. Global Anorexiants Market, by Serotonin, by Region, 2019-2032 (USD Million)

6. Global Anorexiants Market, by Route of Admission

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 6.3. Oral
    • 6.3.1. Global Anorexiants Market, by Oral, by Region, 2019-2032 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Global Anorexiants Market, by Subcutaneous, by Region, 2019-2032 (USD Million)

7. Global Anorexiants Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • 7.3. Institutional sales
    • 7.3.1. Global Anorexiants Market, by Institutional sales, By Region, 2019-2032 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Global Anorexiants Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.5. Clinics
    • 7.5.1. Global Anorexiants Market, by Clinics, By Region, 2019-2032 (USD Million)
  • 7.6. Retail sales
    • 7.6.1. Global Anorexiants Market, by Retail sales, By Region, 2019-2032 (USD Million)
  • 7.7. Online pharmacies
    • 7.7.1. Global Anorexiants Market, by Online pharmacies, By Region, 2019-2032 (USD Million)
  • 7.8. Mail Order Pharmacies
    • 7.8.1. Global Anorexiants Market, by Mail Order Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Anorexiants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Anorexiants Market - North America
    • 8.3.1. North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.3.2. North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.4. Anorexiants Market - U.S.
      • 8.3.4.1. U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.5. Anorexiants Market - Canada
      • 8.3.5.1. Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.4. Anorexiants Market - Europe
    • 8.4.1. Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.4. Anorexiants Market - UK
      • 8.4.4.1. UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.5. Anorexiants Market - France
      • 8.4.5.1. France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.6. Anorexiants Market - Germany
      • 8.4.6.1. Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.7. Anorexiants Market - Italy
      • 8.4.7.1. Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.8. Anorexiants Market - Spain
      • 8.4.8.1. Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.9. Anorexiants Market - Netherlands
      • 8.4.9.1. Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.10. Anorexiants Market - Russia
      • 8.4.10.1. Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.5. Anorexiants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.4. Anorexiants Market - China
      • 8.5.4.1. China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.5. Anorexiants Market - India
      • 8.5.5.1. India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.6. Anorexiants Market - Malaysia
      • 8.5.6.1. Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.7. Anorexiants Market - Japan
      • 8.5.7.1. Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.8. Anorexiants Market - Indonesia
      • 8.5.8.1. Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.9. Anorexiants Market - South Korea
      • 8.5.9.1. South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.6. Anorexiants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.4. Anorexiants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.5. Anorexiants Market - UAE
      • 8.6.5.1. UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.6. Anorexiants Market - Israel
      • 8.6.6.1. Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.7. Anorexiants Market - South Africa
      • 8.6.7.1. South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.7. Anorexiants Market - Latin America
    • 8.7.1. Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.4. Anorexiants Market - Mexico
      • 8.7.4.1. Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.5. Anorexiants Market - Brazil
      • 8.7.5.1. Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.6. Anorexiants Market - Argentina
      • 8.7.6.1. Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca (UK)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Aurobindo Pharma (India)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies Inc. (Canada)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cipla Inc. (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Currax Pharmaceuticals LLC (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eisai Co., Ltd. (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GlaxoSmithKline plc (UK)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Johnson & Johnson Private Limited (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Lannett (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck & Co., Inc. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Mylan N.V. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis AG (Switzerland)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables

  • Table 1 Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 2 Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 3 Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 4 Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 6 North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 7 North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 9 U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 10 U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 12 Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 13 Canada: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 15 Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 16 Europe: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 18 UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 19 UK: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 21 France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 22 France: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 24 Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 25 Germany: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 27 Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 28 Italy: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 30 Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 31 Spain: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 33 Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 34 Netherlands: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 36 Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 37 Russia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 42 China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 43 China: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 45 India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 46 India: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 48 Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 49 Malaysia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 51 Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 52 Japan: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 54 Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 55 Indonesia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 57 South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 58 South Korea: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 66 UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 67 UAE: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 69 Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 70 Israel: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 72 South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 73 South Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 75 Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 76 Latin America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 78 Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 79 Mexico: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 81 Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 82 Brazil: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 84 Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 85 Argentina: Anorexiants Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Anorexiants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Admission
  • Figure 7. Global Anorexiants Market, by Route of Admission, 2022 & 2032 (USD Million)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Anorexiants Market, by Drug Class, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Anorexiants Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Anorexiants Market